Error-augmented Walking on Gait Performance and Brain Activities in Stroke

June 16, 2022 updated by: National Taiwan University Hospital

The Effects of Error-augmented Walking on Gait Performance and Brain Activities in Individuals With Stroke

This three-year study is proposed to document the effect and further implementation of error-augmented walking on gait performance and brain activities in individuals with stroke. Note that brain activations of post-stroke individuals during locomotion is a relatively unexplored realm. In the first year, study aims to observe the gait performance and brain activity of post-stroke and healthy participants when they walk on the split-belt treadmill, which inputs errors and causing adaptation during locomotion. Second year, study focuses on the long-term effect in aspect of brain activation and gait performance after training the post-stroke individuals with error-augmented treadmill walking. Lastly, study aim to investigate the long-term effect of practically applying the concept of error-augmented training strategy into clinical physical therapy.

The first-year study is a cross-sectional study to recruit post-stroke and healthy participants. Gait performance will be measured by GaitUp system and brain activity during each walking trails will be measured concurrently by functional near infrared spectroscopy (fNIRS). Cadence, stride time, stride length and swing cycle are the gait parameters that will be recorded. Also, symmetry ratio and variability of temporal and spatial parameters will also be calculated. Brain area of interest in this study will be bilateral premotor cortex (PMC), supplementary motor area (SMA) and medial part of primary motor cortex (M1). Study will run one-way analysis of variance (ANOVA) with repeated measures and, if needed, Tukey post hoc test will be used to document the within group and between group differences with p<.05.

The second year and third year study are single-blinded (assessor), randomized controlled trials. In the second year, study will recruit and randomize post-stroke participants into one of the two training groups, error-augmented treadmill training group (ETT group) and active control group (AC group). In ETT group, participants will practice split-belt treadmill walking. And participants in AC group will received traditional treadmill walking. The training duration will be 40 minutes per session, 3 sessions per week for a total of 4 weeks for every group. There will be three evaluations, chronologically, on one day before intervention, one day after completion of intervention and one month after completion of intervention. Gait performance, brain activity, dynamic gait index and sensorimotor ability of lower extremity will be documented. Two-way ANOVA and Tukey post-hoc test will be used to determine the training and follow-up effects with p< .05. During the third year, individuals with stroke will be recruited and randomized to one of the two group, error-augmented concept combined physical therapy group (EAPT group) and conventional physical therapy group (CPT group). Participants in the CPT group will receive thirty-minute conventional physical therapy each session. Instead of training on a split-belt treadmill, participants in EAPT group will receive fifteen-minute walking trainings that implement the error-augmented concept and another fifteen-minute conventional physical therapy each session. The training duration will be 40 minutes per session, 3 sessions per week for a total of 4 weeks for every group. The outcome measurements, and statistical analysis are the same as those described in the second year.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

The inclusion criteria of stroke participants are

  1. first unilateral stroke
  2. older than 20 years old
  3. medically stable
  4. lesion site limited in subcortical area
  5. having step length asymmetry (asymmetry ratio ≥ 1.08)
  6. ability to walk 10 meters independently without an assistive device.

The inclusion criteria of healthy participants are

  1. ability to walk 10 meters independently without an assistive device
  2. no any other neurological, psychological, or orthopedic disorders known to interfere the walking performance
  3. mini-mental status examination scores > 24 points

The exclusion criteria are

  1. Participants who are medical unstable
  2. cognitive impaired (mini-mental status examination scores < 24 points)
  3. diagnosed with other neurological, psychological, or orthopedic disorders known to interfere the participation to the study
  4. with the diagnosis which the contraindication includes exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: healthy
year 1 study
NO INTERVENTION
Other: stroke
year 1 study
NO INTERVENTION
Active Comparator: active control group
year 2 study
walk on tie-belt treadmill
Experimental: Error-augmented treadmill training
year 2 study
walk on split-belt treadmill
Experimental: Error-augmented concept combined physical therapy group
year 3 study
Error-augmented concept combined physical therapy
Active Comparator: conventional physical therapy group
year 3 study
conventional physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of walking performance - Cadence
Time Frame: Change from Baseline cadence at 4 weeks
The unit is steps per minutes
Change from Baseline cadence at 4 weeks
Change of walking performance - Cadence
Time Frame: Change from Baseline cadence at 8 weeks
The unit is steps per minutes
Change from Baseline cadence at 8 weeks
Change of walking performance - stride time
Time Frame: Change from Baseline cadence at 4 weeks
The unit is seconds
Change from Baseline cadence at 4 weeks
Change of walking performance - stride time
Time Frame: Change from Baseline cadence at 8 weeks
The unit is seconds
Change from Baseline cadence at 8 weeks
Change of walking performance - stride length
Time Frame: Change from Baseline cadence at 4 weeks
The unit is cm
Change from Baseline cadence at 4 weeks
Change of walking performance - stride length
Time Frame: Change from Baseline cadence at 8 weeks
The unit is cm
Change from Baseline cadence at 8 weeks
Change of walking performance - swing cycle
Time Frame: Change from Baseline cadence at 4 weeks
The unit is percentage (%)
Change from Baseline cadence at 4 weeks
Change of walking performance - swing cycle
Time Frame: Change from Baseline cadence at 8 weeks
The unit is percentage (%)
Change from Baseline cadence at 8 weeks
Change of walking performance - symmetry ratio
Time Frame: Change from Baseline cadence at 4 weeks
V(larger value) / V(lesser value), V=step length(spatial) or step time(temporal)
Change from Baseline cadence at 4 weeks
Change of walking performance - symmetry ratio
Time Frame: Change from Baseline cadence at 8 weeks
V(larger value) / V(lesser value), V=step length(spatial) or step time(temporal)
Change from Baseline cadence at 8 weeks
Change of walking performance - variability
Time Frame: Change from Baseline cadence at 4 weeks
CV(coefficient of variation) = standard deviation/mean x 100% of the stride length(spatial) or stride time(temporal)
Change from Baseline cadence at 4 weeks
Change of walking performance - variability
Time Frame: Change from Baseline cadence at 8 weeks
CV(coefficient of variation) = standard deviation/mean x 100% of the stride length(spatial) or stride time(temporal)
Change from Baseline cadence at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain activities over premotor cortex
Time Frame: Change from Baseline cadence at 4 weeks
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
Change from Baseline cadence at 4 weeks
Brain activities over premotor cortex
Time Frame: Change from Baseline cadence at 8 weeks
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
Change from Baseline cadence at 8 weeks
Brain activities over supplementary motor area
Time Frame: Change from Baseline cadence at 4 weeks
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
Change from Baseline cadence at 4 weeks
Brain activities over supplementary motor area
Time Frame: Change from Baseline cadence at 8 weeks
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
Change from Baseline cadence at 8 weeks
Brain activities over primary motor cortex
Time Frame: Change from Baseline cadence at 4 weeks
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
Change from Baseline cadence at 4 weeks
Brain activities over primary motor cortex
Time Frame: Change from Baseline cadence at 8 weeks
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
Change from Baseline cadence at 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Gait Index
Time Frame: Change from Baseline cadence at 4 weeks
Change from Baseline cadence at 4 weeks
Dynamic Gait Index
Time Frame: Change from Baseline cadence at 8 weeks
Change from Baseline cadence at 8 weeks
Fugl-Meyer assessment
Time Frame: Change from Baseline cadence at 4 weeks
Sensorimotor impairment of lower extremity
Change from Baseline cadence at 4 weeks
Fugl-Meyer assessment
Time Frame: Change from Baseline cadence at 8 weeks
Sensorimotor impairment of lower extremity
Change from Baseline cadence at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yanci Liu, Ph.D, National Taiwan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 13, 2020

Primary Completion (Anticipated)

June 3, 2023

Study Completion (Anticipated)

July 31, 2023

Study Registration Dates

First Submitted

June 22, 2020

First Submitted That Met QC Criteria

June 28, 2020

First Posted (Actual)

July 2, 2020

Study Record Updates

Last Update Posted (Actual)

June 21, 2022

Last Update Submitted That Met QC Criteria

June 16, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on NO INTERVENTION

3
Subscribe